Weight loss typically begins in the first few weeks and continues steadily throughout treatment
The best thing you can do right now is track your tirzepatide outcomes carefully, know your cardiovascular baseline, and have a specific conversation with your prescriber about your plateau status
Tirzepatide is a dual agonist, meaning it targets two different hormone receptors: the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor
And so its not going anywhere. HR Director, Large manufacturer While there was a great deal of concern expressed about the ability of employers to afford the potential costs for covering these drugs more broadly, many also acknowledged that the pressure to cover them was likely to continue
Even berberine (the main ingredient in many patches) has poor skin penetration due to its size and structure
Explaining the approval process can help manage expectations